Parity, Early Menopause and the Incidence of Bladder Cancer in Women: A Case-Control Study and Meta-Analysis

Por Dietrich, K, Demidenko, E, Schned, A, Zens, MS, Heaney, J, Karagas, MR
Publicado em 2010

Glucocorticoid therapy and risk of bladder cancer

Por Dietrich, K, Schned, A, Fortuny, J, Heaney, J, Marsit, C, Kelsey, K T, Karagas, M R
Publicado em 2009

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer

Por Kelsey, K T, Hirao, T, Schned, A, Hirao, S, Devi-Ashok, T, Nelson, H H, Andrew, A, Karagas, M R
Publicado em 2004

DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer

Por Wilhelm-Benartzi, C.S., Koestler, D.C., Houseman, E.A., Christensen, B.C., Wiencke, John K., Schned, A.R., Karagas, M.R., Kelsey, K.T., Marsit, C.J.
Publicado em 2010

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis

Por Moore, L.E., Baris, D.R., Figueroa, J.D., Garcia-Closas, M., Karagas, M.R., Schwenn, M.R., Johnson, A.T., Lubin, J.H., Hein, D.W., Dagnall, C.L., Colt, J.S., Kida, M., Jones, M.A., Schned, A.R., Cherala, S.S., Chanock, S.J., Cantor, K.P., Silverman, D.T., Rothman, N.
Publicado em 2011